세계의 한랭 요법 시장 : 제품, 용도, 치료 유형, 유통 채널, 지역별(2024-2031년)

Cold Pain Therapy Market Valuation - 2024-2031

Increasing awareness of the benefits of non-invasive pain management solutions is driving the market size of the market. According to the analyst from Verified Market Research, the Cold Pain Therapy Market is estimated to reach a valuation of USD 1552.62 Million over the forecast subjugating around USD 1071.92 Million valued in 2024.

The rapid expansion of the cold pain therapy market is primarily driven by the rising prevalence of chronic pain conditions, which is leading to increased demand for effective pain relief options. It enables the market to grow at aCAGR of 4.74% from 2024 to 2031.

Cold Pain Therapy Market: Definition/ Overview

Cold pain therapy is a treatment method that utilizes cold temperatures to alleviate pain and reduce inflammation. Various modalities, including ice packs, gel packs, and cryotherapy devices, are employed in this therapy to provide targeted pain relief for acute injuries, postoperative recovery, and chronic pain conditions. The effectiveness of cold therapy in numbing pain and minimizing swelling has been recognized across multiple medical disciplines, including orthopedics, sports medicine, and physical rehabilitation.

Increasing demand for non-invasive and drug-free pain management solutions is being driven by a growing awareness of the benefits associated with cold pain therapy. Factors such as the rising incidence of sports-related injuries and musculoskeletal disorders, along with an aging population prone to chronic pain conditions, are contributing to the market's expansion. As healthcare professionals continue to endorse cold therapy as an effective treatment option, the market for cold pain therapy is anticipated to experience significant growth in the coming years.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What Impact is the Rising Prevalence of Chronic Pain Conditions having on the Cold Pain Therapy Market?

The rising prevalence of chronic pain conditions is significantly impacting the cold pain therapy market by increasing the demand for effective pain management solutions. According to the Centers for Disease Control and Prevention (CDC), in 2019, an estimated 20.4% of U.S. adults (50.2 million) had chronic pain, and 7.4% of adults (19.6 million) had high-impact chronic pain that frequently limited life or work activities. Various factors, including the aging population and lifestyle-related issues, have contributed to the escalation of chronic pain cases. Consequently, the need for non-invasive and drug-free treatment options has been emphasized by healthcare providers, leading to an uptick in the adoption of cold therapy modalities.

As patients seek alternatives to pharmacological treatments, the therapeutic benefits of cold pain therapy are being recognized more widely. Market growth is further supported by ongoing research that highlights the efficacy of cold therapy in reducing pain and inflammation. As awareness increases, the adoption of cold pain therapy is anticipated to grow, thereby driving the overall market expansion.

How are Technological Advancements in Cold Therapy Devices Influencing the Market Growth?

Technological advancements in cold therapy devices are influencing market growth by enhancing the effectiveness and user experience of cold pain therapy. Innovations, such as portable cryotherapy machines and smart ice packs with adjustable temperature controls, have been developed, allowing for more targeted and efficient pain management. The integration of features such as timers and mobile applications has made these devices more accessible and user-friendly.

Furthermore, clinical studies supporting the efficacy of these advanced devices have bolstered their credibility in medical settings. As healthcare providers become more informed about these innovations, recommendations for their use in pain management are being made more frequently. This trend is leading to an increased market share for technologically advanced cold pain therapy solutions, thereby positioning them as preferred choices among patients and healthcare professionals alike.

Category-Wise Acumens

What Factors are Contributing to the Dominance of OTC-Based Products in the Cold Pain Therapy Market?

According to VMR Analyst, the dominance of OTC-based products in the Cold Pain Therapy market is being driven by several key factors. Increasing consumer preference for self-management of pain has resulted in a higher demand for over-the-counter solutions, which are perceived as convenient and accessible. As awareness regarding the benefits of cold therapy for pain relief grows, more individuals are opting for OTC options rather than seeking prescription treatments.

The affordability of these products compared to prescription alternatives has also contributed to their popularity. Furthermore, marketing strategies that highlight the effectiveness of OTC cold therapy products have been widely adopted by manufacturers, thereby increasing visibility in retail settings. The regulatory landscape has supported the proliferation of these products, enabling easier access for consumers. Consequently, OTC-based products are expected to maintain a significant share of the market as consumer habits continue to evolve.

What Trends are Driving the Rapid Growth of Online Pharmacies as a Distribution Channel for Cold Pain Therapy Products?

The rapid growth of online pharmacies as a distribution channel for cold pain therapy products is being propelled by changing consumer behaviors and advancements in e-commerce. Increasing preferences for convenience and accessibility have led to a surge in online shopping for healthcare products, including cold therapy solutions. The COVID-19 pandemic has further accelerated this trend, as more consumers have turned to digital platforms for their healthcare needs to minimize exposure in physical stores.

Online pharmacies are being favored for their ability to provide a wide range of products, often at competitive prices. Enhanced delivery options and user-friendly interfaces have made the purchasing process more efficient, attracting a broader customer base. Additionally, targeted marketing and promotions have been employed by online retailers to capture consumer interest. As a result, the market share of online pharmacies is anticipated to expand significantly, reflecting a fundamental shift in how consumers access cold pain therapy products.

Country/Region-wise Acumens

What Factors are Contributing to North America's Dominance in the Cold Pain Therapy Market?

According to VMR analyst, North America's dominance in the cold pain therapy market is being attributed to several influential factors. High levels of healthcare expenditure in the region have facilitated widespread access to advanced therapeutic options, allowing patients to benefit from various cold pain therapy products. A strong emphasis on research and development by leading healthcare companies has resulted in innovative cold therapy solutions that are highly regarded in clinical settings.

Furthermore, the prevalence of chronic pain conditions and sports-related injuries in North America has created significant demand for effective pain management solutions. The influence of healthcare professionals advocating for non-invasive treatment options has further solidified the market position of cold therapy products. Consequently, North America is expected to retain a substantial share of the cold pain therapy market as consumer awareness and demand continues to grow.

How is the Rapid Growth of the Cold Pain Therapy Market Being Supported by Asia Pacific's Increasing Healthcare Expenditures?

According to VMR analyst, the rapid growth of the cold pain therapy market in the Asia Pacific is being supported by increasing healthcare expenditures and a rising population awareness regarding pain management solutions. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of older persons (aged 65 and above) in the Asia-Pacific region is expected to more than double from 535 million in 2015 to about 1.3 billion by 2050. Economic development in several countries within the region has led to improved healthcare infrastructure, making advanced therapy options more accessible to the general population.

The growing prevalence of chronic pain and injuries due to active lifestyles has heightened the demand for effective and convenient pain relief methods. Furthermore, government initiatives promoting health awareness and access to medical products have bolstered market growth. As consumers increasingly recognize the benefits of cold therapy for pain management, investments in healthcare technologies are being prioritized.

Competitive Landscape

The Cold Pain Therapy Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the cold pain therapy market include:

3M Company

Beiersdorf AG

Breg, Inc.

DJO Finance LLC

Hisamitsu Pharmaceutical Co., Inc.

Johnson & Johnson

Medline Industries, Inc.

Rohto Pharmaceutical Co., Ltd.

Latest Developments

In April 2021, Battle Creek Equipment Co. announced the launch of a line of cold therapy wraps to assist in alleviating chronic pain, acute pain, and inflammation.

In March 2019, Performance Health increased its product offering with the introduction of the Biofreeze pain treatment patch.

In 2019, Performance Health announced the launch of the Cold Patches Biofreeze Pain Relief Patch.

In 2019, DJO Global developed the cooling pads DonJoy IceMan Classic 3.

In February 2021, Breg established announced a partnership with Club Warehouse to enhance the delivery of its high-value orthopedic products in Australia. The company intends to distribute its products throughout the continent, including Australian Football League, National Rugby League, and Rugby Union Clubs.

In December 2020, Sanofi reaffirmed announced a partnership with WHO to combat some neglected diseases and eliminate sleeping sickness by 2030. Sanofi provides a specific amount of financial support for disease management, campaigns, drug donations, and so on. The cooperation is already 20 years old and helps with the screening, control, and treatment of sleeping sickness, one of the most neglected tropical diseases.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL COLD PAIN THERAPY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL COLD PAIN THERAPY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL COLD PAIN THERAPY MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 OTC Products
  • 5.2.1 Creams
  • 5.2.2 Gels
  • 5.2.3 Patches
  • 5.2.4 Others
• 5.3 Prescription Products
  • 5.3.1 Pharmaceuticals
  • 5.3.2 Medical Devices

6 GLOBAL COLD PAIN THERAPY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Musculoskeletal Disorders
• 6.3 Post-Operative Therapy
• 6.4 Post-Trauma Therapy
• 6.5 Sports Medicine

7 GLOBAL COLD PAIN THERAPY MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL COLD PAIN THERAPY MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Breg, Inc
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Beiersdorf AG
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 A-ssur HF
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 3M Company
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 DJO Finance LLC
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Hisamitsu Pharmaceutical Co., Inc
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Johnson & Johnson
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Medline Industries, Inc
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Rohto Pharmaceutical Co., Ltd
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sanofi
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research